The Latest Breaking News from Johnson

Lawsuits have claimed product contains asbestos and causes cancer which company denies

Rising inflation, the Fed’s hawkish stance to tame it, and an economic contraction for two consecutive quarters have stoked fears of a recession in the U.S. economy. Amid the likely economic downturn, investors could consider investing in stocks that provide a steady income in the form of dividends. Therefore, we…

The stock market has been experiencing immense volatility lately as investors remain concerned over the multi-decade high inflation and the Fed’s aggressive interest rates to control it. However, fundamentally sound stocks Johnson & Johnson (JNJ), Coca-Cola FEMSA (KOF), KT Corporation (KT), and Weis Markets (WMK) are outperforming the broader market.…

Chelsea have confirmed members of their new board following the planned departures of Marina Granovskaia and Bruce Buck

Given the current market turmoil caused due to surging inflation and the Fed’s aggressive interest rate hikes to bring prices down, it could be wise to invest in stocks that do not fluctuate significantly in adverse market conditions. The solid stability of Johnson & Johnson (JNJ), Coca-Cola FEMSA (KOF), Marubeni…

An era is over. We have come to the end of the road.

Production of Johnson & Johnson jab at Hyderabad-based firm’s facility stalled over indemnity and safety issues

The use of Johnson and Johnson’s COVID-19 vaccine, also known as Janssen, has been limited to “certain individuals” over rare blood clot risks, the U.S. Food and Drug Administration announced Thursday, May 5.

The chances of dying following after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine.

After more than two years, tourists can finally return

Booster or natural infection will reduce the chance of another infection for just a few months, they say.